The aim of current study is to develop novel strategies to efficiently kill ESCC tumor cells by utilizing recently developed Mcl-1 inhibitor A-1210477 that directly activate the cell death pathway. The gene discussed is MCL1; the disease is esophageal squamous cell carcinoma.